- Home
- Eltrompact 50 Tablet 14's
Eltrompact 50 Tablet 14's Substitute
Eltrompact 50 Tablet 14's Substitute
Verified Ingredients and Effects
Composition:
ELTROMBOPAG-50MG
Uses:
<p>Eltrompact 50 Tablet 14's is used to treat low platelet count and severe aplastic anemia (SAA). The detailed uses of Eltrompact 50 Tablet 14's are as follows:</p><ul><li><strong>Chronic immune thrombocytopenia (ITP):</strong> Eltrompact 50 Tablet 14's helps prevent excessive bleeding in patients with low platelet counts.</li><li><strong>Severe aplastic anemia:</strong> Eltrompact 50 Tablet 14's is used to treat severe aplastic anemia when other treatments have failed.</li><li><strong>Chronic hepatitis C-related thrombocytopenia:</strong> Eltrompact 50 Tablet 14's helps maintain platelet levels before and during interferon therapy.</li></ul>
Medicinal Benefits:
Eltrompact 50 Tablet 14's contains 'Eltrombopag,' which belongs to the class of 'thrombopoietin receptor agonists' used to treat low blood platelet count in patients with immune (idiopathic) thrombocytopenic purpura (ITP), hepatitis C virus (HCV) infections, and severe aplastic anemia (SAA). Eltrompact 50 Tablet 14's works by increasing megakaryocytes, the large bone marrow cells responsible for the production of platelets. The increase in these bone marrow cells stimulates the production of platelets. Thus, Eltrompact 50 Tablet 14's prevents bleeding episodes by increasing the number of platelets in the blood.
FAQs
Eltrompact 50 Tablet 14's is used to treat low blood platelet count in patients with idiopathic thrombocytopenic purpura (ITP) and hepatitis C virus (HCV) infections. It is also used to treat severe aplastic anemia (SAA).
Eltrompact 50 Tablet 14's contains Eltrombopag that stimulates platelet production (helps in clotting) from megakaryocytes (bone marrow cells). Thus Eltrompact 50 Tablet 14's lowers the risk of bleeding episodes in diseases like immune (idiopathic) thrombocytopenic purpura (ITP), hepatitis C virus (HCV) infections, and severe aplastic anemia (SAA).
Do not stop using Eltrompact 50 Tablet 14's even if you feel better. It should be strictly used as advised by your doctor to avoid the recurrence of symptoms and worsening of the disease.
Eltrompact 50 Tablet 14's should be used with caution and only under doctor supervision in cases if you are having any allergic reactions, blood clots, clotting disorders (Factor V Leiden), blood disorders like blood cancer, myelodysplastic syndrome, cataracts, liver or kidney diseases.
Eltrompact 50 Tablet 14's decreases the risk of bleeding by increasing the platelet count in your body. However, you are advised to stay away from activities that may increase your risk of bleeding like contact sports and using sharp objects like razors and nail cutters.
It is advised to take Eltrompact 50 Tablet 14's on an empty stomach. Please take Eltrompact 50 Tablet 14's at least two hours before or four hours after consuming antacids, mineral and vitamin supplements (iron, calcium, magnesium, aluminium, selenium, and zinc), dairy products, calcium-enriched foods, and fortified juices since they interfere with the absorption of Eltrompact 50 Tablet 14's.
It is usually taken by mixing the prescribed amount of suspension powder in water and administering it orally immediately after ensuring perfect mixing.
Eltrompact 50 Tablet 14's should be stored in a cool and dry place away from sunlight. Keep out of sight and reach of children.
Eltrompact 50 Tablet 14's can cause or increase the risk of severe liver issues. Check with your doctor straight away if you experience nausea or vomiting, dark urine, light-coloured stools, right upper stomach pain, unusual exhaustion, or yellow eyes or skin while using this medication.
